United States: Corporate Law & Governance Update - March 2017

Executive Compensation Developments

The general counsel should anticipate questions from the board and its executive compensation committee from recent media coverage of executive compensation (especially in the nonprofit sector). This increased focus has concentrated on issues relating to reasonableness of compensation, and the use of compensation to reward particular organization and individual success—and to hold executives accountable for shortfalls in leadership or performance.

Media attention to nonprofit executive compensation is nothing new, and data contained in Form 990 filings should always be expected to "see the light of day." The general counsel can address related concerns by advising her internal board/committee clients to focus on the following critical factors: (a) the comprehensive nature of the board's executive compensation approval process and the strength of the position on the "Rebuttable Presumption"; (b) familiarity with all individual components of an executive's compensation package; (c) the increasing responsibilities of corporate executives given growth in organizational size and complexity; (d) the exercise of independent business judgment by the compensation committee; and (e) the continuing ability of the health system to operate in a manner consistent with its charitable purposes.

The compensation committee may also seek guidance on how compensation is being used more broadly by sophisticated enterprises to drive behavior, incentivize conduct and penalize performance that falls short of board expectations. The general counsel may wish to team with the chief human resources officer on a board briefing that anticipates these questions.

New DOJ Compliance Program Guidance

Health system audit and compliance committees will want to review the new compliance program guidance recently issued by the Fraud Section of the Department of Justice (DOJ). While not specific to the health industry, it nevertheless provides a practical set of benchmarks against which the audit and compliance committees, in consultation with the general counsel and the chief compliance officer, can evaluate the effectiveness of the health system's compliance program.

The Guidance is presented in the form of a series of substantive compliance-focused questions that the DOJ frequently considers when evaluating a corporate compliance program. Questions particularly relevant to health care organizations include those that focus on the conduct of senior and middle management; the internal stature of the compliance function; the autonomy of the compliance function; program funding and resources; corporate response to expressed compliance concerns; the process for responding to investigative findings; consistency of disciplinary measures; and periodic updating of procedures and practices. Important questions focus on the board's exercise of its compliance oversight duties—including whether relevant expertise is available on the board, and how compliance-related information is provided to the board.

The release of this Guidance is a significant development in terms of assuring the most effective corporate compliance plan possible. It is directly relevant to the fiduciary obligations of the board's audit and compliance committee; to which the health system general counsel, in consultation with the compliance officer, may provide a briefing.

M&A Strategic Planning

The health system's M&A planning should closely consider the implications of the government's latest litigation victory in its challenge to a concentrated market hospital merger. The strategic planning committee would benefit from a briefing on the March 7 decision enjoining the proposed Advocate Healthcare Network/NorthShore University Health System merger in the Chicago area.

The District Court granted the Federal Trade Commission (FTC) and the State of Illinois a preliminary injunction blocking the merger from closing, pending an administrative trial on the merits before an FTC administrative law judge. Rather than continue to litigate, Advocate and NorthShore immediately announced their intention to abandon their proposed merger.

This is the second decision in a year in which the FTC has successfully challenged, by litigation, a concentrated hospital market merger (the other being the proposed Penn State Hershey/PinnacleHealth System merger in Pennsylvania). Both decisions adopted the FTC's approach to defining geographic markets by taking into account the views of payors and, specifically, what alternatives to the merging parties they believed they had in negotiations to form a provider network to market to employers and individuals.

It should also be noted that in both the Hershey and Advocate cases, the FTC voted unanimously for the filing of a complaint; there was no split among the FTC's Republican and Democratic commissioners along political lines.

The Corporate Ethics Officer

One of the unanticipated side effects of the intensive focus on the President's personal conflicts issues is increased interest in the creation of a new "chief ethics officer" position. Yet the wisdom and practicality of creating a separate executive position requires careful and dispassionate board-level review, in consultation with general counsel.

Some companies (e.g., the Trump Organization) may find assigning oversight of ethical obligations to a dedicated corporate executive or outside adviser to be an effective strategy for addressing business conduct. But there is no broadly accepted portfolio for the role of a separate ethics officer, nor understanding of how such a role might encroach on the existing duties of the general counsel or the chief compliance officer. In addition, there is no general agreement on the qualifications for such a position, even though the evaluation of conflicts of interest and interpretation of federal ethical guidelines usually requires legal training.

Boards should therefore pause before treating the related actions of the Trump Organization and of the White House as a governance corporate best practice, as meritorious as those actions may otherwise be.

Corporate Officers as Corporate Agents

In the current corporate accountability environment, the extent to which state law treats corporate officers (but not directors) as agents of the corporation may have increasingly important implications. This treatment may affect how the general counsel advises corporate leadership in certain situations.

A new scholarly article provides a helpful discussion of the distinctive fiduciary relationship of officers to the corporation. It confirms those duties that officers and directors share (e.g., the loyalty triad), and those that may be peculiar to officers (e.g., performance-related duties that include both a duty to comply with reasonable instructions and a duty to share material information with the board ). These unique agency-related duties form the basis of the corporation's authority to exercise control over officer conduct.

Depending upon specific state law, the characterization of corporate officers as agents may affect the legal analysis applied to the evaluation of such matters as an officer's performance, standard of conduct, reliance, scope of authority, and indemnification and advancement rights, and the interpretation of employment contracts. This is a topic of increasing academic debate. The general counsel should thus note the potential that fiduciary and other laws may apply differently to officers than they do directors.

"Long Stay" Directors

Issues regarding director tenure continue to be a board challenge. A recent The Wall Street Journal article speaks to concerns of institutional investors with the "long stay director"; i.e., a director who has been on the board for more than 12 years.

The article cites data suggesting that only a small percentage of S&P companies have term limits and that independent directors at more than 100 such companies have served for 25 years or more. Thus, an increasing number of investor groups are either (a) opposing the re-election of long stay directors; or (b) requesting that the performance of such directors be vigorously reviewed and/or they be classified as non-independent.

These questions of tenure and compromised independence are absolutely relevant to nonprofit health system boards, many of which greatly value the unique experience of long stay directors. In the absence of best practices, governance committees should remain engaged on this issue.

Meaningful Committee Service

A recent article from the Chronicle of Higher Education identifies steps that can be taken to make committee service more meaningful to its members and the board. Many of these steps are relevant to committees of nonprofit health system boards.

The article recognizes a number of concerns, including (i) a large number of committees and a small (board) pool from which to draw members; (ii) lack of recognition from committee service; and (iii) limited staff support for the committee's agenda.

It also prompts consideration of a number of proactive solutions, including updating the committee charter; making the work of the committee more visible to the full board; including non-directors as committee members, as law allows; monitoring the work load between committees; and assuring dedicated executive team resources to support the committee's work.

Given the heavy reliance the health system board places on the role of committees, the governance committee may want to consider ways of enhancing the value and materiality of committee service.

Risk Oversight Duties

There is an increasing acceptance that risk management, in all of its permutations, transcends the duties of management to become a prominent responsibility of the board. The general counsel is well advised to brief the board on the elements of this responsibility.

Several new best practices compilations are available to help clarify for the board its responsibilities with respect to the oversight of a health system's risks. These include those published by The Business Roundtable, the National Association of Corporate Directors (NACD) and The Conference Board.

As most general counsel are aware, the historical judicial threshold in most states for breach of the risk oversight obligation is very high. However, in a recent publication, a prominent governance authority warns of the potential for egregious fact patterns to drive unfavorable outcomes, particularly in jurisdictions outside of Delaware.

For this and other reasons, the general counsel may want to encourage the board to revisit its approach to oversight of risk management; using state case law and these best practices compilations as benchmarks. The value of such an exercise exists regardless of whether the health system has an existing enterprise risk management program.

The Relevance of Jobs Data

There are increasing indications that jobs-related data may be a valuable evaluation resource for several key committees of the health system board. Such data would include, but would not be limited to, information provided by the Department of Labor and other sources with respect to trends in hiring, jobs creation, the employment rate and the consumer price index.

A critical, but often overlooked, aspect of the duty of care is the obligation to monitor economic conditions (both national and global) and their implications for both the health care industry in general, and the individual health system the board serves. Part of that monitoring can focus on the pulse of the job market, and what employment trends are suggesting. Such data can offer important indications as to general and industry specific financial conditions; about what sectors and business lines are creating the most jobs (e.g. ambulatory care and home health); access to a pool of qualified employees, and the implications of job loss indicators and workforce reductions.

Such data can be useful to the board, particularly as it relates to strategic planning, human resources and talent development oversight responsibilities. The general counsel can help identify how this data can be effectively incorporated into the committee agenda and interpreted by its members.

Evolving Cybersecurity Duties

There are probably few topics that health system directors are more tired of hearing about than cybersecurity oversight obligations. But general counsel may need to return to that topic one more time, given the release of a new "best practices" compilation.

Recently, the National Association of Corporate Directors (NACD) issued its new resource, "NACD Director's Handbook on Cyber Risk Oversight." Key topics covered include (i) the proper allocation of cyber risk responsibilities at the board level; (ii) the legal implications related to cybersecurity; (iii) board-to-management expectations on cybersecurity processes; and (iv) improving dialogue between the board and management on cybersecurity matters.

The release of the newest NACD guidelines is a reminder of how quickly and significantly the technological, regulatory enforcement and fiduciary duty landscape is changing in the area of cybersecurity—especially in health care. The general counsel (perhaps teaming with the chief information officer) might use the release as a prompt to revisit the continued effectiveness of current board cyber risk oversight processes.

Corporate Law & Governance Update - March 2017

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
McDermott Will & Emery
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
McDermott Will & Emery
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions